medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (3)


Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites

Liu F, Kong X, Dou Q, Ye J, Xu D, Shang H, Xu K, Song Y

Idioma: Ingles.
Referencias bibliográficas: 25
Paginas: 357-363
Archivo PDF: 86.88 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-56.

  2. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49: 2087-107.

  3. Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006; 42: 589-97.

  4. Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 2012; 4: 87-95.

  5. Pinto MM. CA-15.3 assay in effusions: comparison with carcinoembryonic antigen and CA-125 assay and cytologic diagnosis. Acta Cytol 1996; 40: 437-42.

  6. Cascinu S, Del Ferro E, Barbanti I, Ligi M, Fedeli A, Catalano G. Tumor markers in the diagnosis of malignant serous effusions. Am J Clin Oncol 1997; 20: 247-50.

  7. Ammon A, Eiffert H, Reil S, Beyer JH, Droese M, Hiddemann W. Tumor-associated antigens in effusions of malignant and benign origin. Clin Investig 1993; 71: 437-44.

  8. Jenkins PF, Ward MJ. The role of peritoneal biopsy in the diagnosis of ascites. Postgrad Med J 1980; 56: 702-3.

  9. Luck NH, Khan AA, Alam A, Butt AK, Shafquat F. Role of laparoscopy in the diagnosis of low serum ascites albumin gradient. J Pak Med Assoc 2007; 57: 33-4.

  10. Chen SJ, Wang SS, Lu CW, Chao Y, Lee FY, Lee SD, Wu SL, et al. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites. J Gastroenterol Hepatol 1994; 9: 396-400.

  11. Loewenstein MS, Rittgers RA, Feinerman AE, Kupchik HZ, Marcel BR, Koff RS, Zamcheck N. Carcinoembryonic antigen assay of ascites and detection of malignancy. Ann Intern Med 1978; 88: 635-8.

  12. Passebosc-Faure K, Li G, Lambert C, Cottier M, Gentil-Perret A, Fournel P, Perol M, et al. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. Clin Cancer Res 2005; 11: 6862-7.

  13. Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez- Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004; 126: 1757-63.

  14. Shahab N. Tumor markers in malignant ascites. Arch Intern Med 2002; 162: 949-50.

  15. Singer G, Rebmann V, Chen YC, Liu HT, Ali SZ, Reinsberg J, McMaster MT, et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003; 9: 4460-4.

  16. Tuzun Y, Celik Y, Bayan K, Yilmaz S, Dursun M, Canoruc F. Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt? J Int Med Res 2009; 37: 79-86.

  17. Tuzun Y, Yilmaz S, Dursun M, Canoruc F, Celik Y, Cil T, Boyraz T. How to increase the diagnostic value of malignancy- related ascites: discriminative ability of the ascitic tumour markers. J Int Med Res 2009; 37: 87-95.

  18. Wang T, Qian X, Wang Z, Wang L, Yu L, Ding Y, Liu B. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions. Int J Cancer 2009; 125: 1921-5.

  19. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8: 1104-9.

  20. Wu SS, Lin OS, Chen YY, Hwang KL, Soon MS, Keeffe EB. Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol 2001; 34: 215-21.

  21. Bedrossian CW. Diagnostic problems in serous effusions. Diagn Cytopathol 1998; 19: 131-7.

  22. Nguyen HN. Extreme CA125 elevation from hepatitis C and ascites. Gynecol Oncol 1998; 70: 441-2.

  23. Runyon BA. Malignancy-related ascites and ascitic fluid “humoral tests of malignancy”. J Clin Gastroenterol 1994; 18: 94-8.

  24. Sevinc A, Sari R, Buyukberber S. Cancer antigen 125: tumor or serosal marker in case of ascites? Arch Intern Med 2001; 161: 2507-8.

  25. Zuckerman E, Lanir A, Sabo E, Rosenvald-Zuckerman T, Matter I, Yeshurun D, Eldar S. Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis. Am J Gastroenterol 1999; 94: 1613-8.




2020     |     www.medigraphic.com